Veículo
Hexbyte Inc (EUA)
Em 2022: 0 notícias
Desde 1995: 2 notícias
Hexbyte Glen Cove Modified protein from rattlesnake venom permits development of drug to modulate blood clotting
Publicado em 02 dezembro 2021
Researchers in Brazil and Belgium have developed a molecule of pharmaceutical interest from collinein-1, a protein found in rattlesnake venom. They used a technique called PEGylation to make the molecule, now called PEG-rCollinein-1, more stable in the organism and resistant to the immune system, obtaining a drug candidate to modulate blood clotting.
An article reporting the results of the research has recently been published in the International Journal of Biological [...]
-
Hexbyte Glen Cove Startup develops yeast-based COVID-19 diagnostic test
Publicado em 30 janeiro 2021Incubated at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, and supported by São Paulo Research Foundation- FAPESP’s Innovative Research in Small Business Program (PIPE), BIOinFOOD is a startup that is developing a rapid COVID-19 diagnostic test based on a patent application filed by students at UNICAMP’s Genomics and Bioenergy Laboratory. The test is based on a biosensor consisting of a genetically modified brewer’s yeast (Saccharomyces [...]ver notícia